Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 135 (Pt 3), 900-11

A Representative Cohort of Patients With Non-Progressive Multiple Sclerosis at the Age of Normal Life Expectancy

Affiliations

A Representative Cohort of Patients With Non-Progressive Multiple Sclerosis at the Age of Normal Life Expectancy

Bengt Skoog et al. Brain.

Abstract

Multiple sclerosis may have a non-progressive symptomatology for decades; however, it is not clear whether the disease activity may abate completely. We identified a cohort of patients, resident in Gothenburg at the time of disease onset, between the years 1950-64 (n = 307). These geographical and temporal restrictions, along with favourable conditions for a 'spider' epidemiological study, were optimal for an unbiased selection; this 15-year incidence cohort was essentially followed prospectively for 37-59 years after onset. The shortest follow-up time for patients without primary or secondary progression was 45 years. For patients with an initial relapsing-remitting course and multiple sclerosis diagnosis according to the Poser criteria (n = 202), the probability of non-progressive disease after 40 years was 22% (standard error 3.0%), and after 50 years it was 14% (standard error 3.2%). For attack onset including patients with possible multiple sclerosis, the corresponding probabilities after 40 and 50 years were 35% (standard error 3.3%) and 28% (standard error 3.5%), respectively. At the last follow-up in 2009-10, when patients reached the average age of the Swedish population life expectancy, only 13 patients from the multiple sclerosis diagnosis cohort, according to the Poser criteria, remained alive and non-progressive. Their annualized attack frequency diminished with time from 0.29 to 0.015. These patients had been functioning well socially. Nine patients had an Expanded Disability Status Scale score of 0-2.5, and four patients had a score of 3 or 3.5, with deficits dating back to attacks decades ago. Eight patients participated in a complete neuropsychological examination, which showed a slight difference (P < 0.01) concerning verbal memory and executive function compared to an age and socially matched reference group, whereas results for five other cognitive domains were within the normal range. Magnetic resonance images fulfilled the Barkhof-Tintoré criteria for multiple sclerosis in 10 of 11 patients, with conspicuously few subcortical lesions relative to extensive periventricular lesions and lesions extending from the inferior midline aspect of the corpus callosum. Prediction of the non-progressive stage was possible with moderate hazard ratios and low sensitivity. Early features that predicted a non-progressive course were complete remission of the onset attack, low or moderate initial relapse frequency and-when the patients with possible multiple sclerosis were included-dominating afferent symptoms. The clinical disease activity had abated in these 13 patients, with the caveat that transition to secondary progression continued to occur after four decades, albeit with decreasing risk.

Similar articles

  • Natural History of Multiple Sclerosis: A Unifying Concept
    C Confavreux et al. Brain 129 (Pt 3), 606-16. PMID 16415308.
    Multiple sclerosis can follow very different patterns of evolution and variable rates of disability accumulation. This raises the issue whether it represents one or sever …
  • Relapses and Progression of Disability in Multiple Sclerosis
    C Confavreux et al. N Engl J Med 343 (20), 1430-8. PMID 11078767.
    Among patients with multiple sclerosis, relapses do not significantly influence the progression of irreversible disability.
  • The Natural History of Primary Progressive Multiple Sclerosis
    M Koch et al. Neurology 73 (23), 1996-2002. PMID 19996074.
    We identified 2 predictors of a slower disease progression in primary progressive multiple sclerosis. Sensory onset symptoms were associated with both a longer time to an …
  • Natural History of Multiple Sclerosis: Risk Factors and Prognostic Indicators
    S Vukusic et al. Curr Opin Neurol 20 (3), 269-74. PMID 17495619. - Review
    Overall course and prognosis in multiple sclerosis is most likely to be related to age and the occurrence of the progressive phase of the disease, rather than to relapses …
  • Pediatric Multiple Sclerosis
    S Bigi et al. J Child Neurol 27 (11), 1378-83. PMID 22914372. - Review
    Pediatric multiple sclerosis has been increasingly recognized in the past 10 to 15 years; 3% to 5% of all multiple sclerosis patients experience their first attack in chi …
See all similar articles

Cited by 11 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback